Patents by Inventor Robert I. Fox

Robert I. Fox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative
    Patent number: 5571800
    Abstract: A method for suppressing the rejection of an allograft comprising administering azaribine at a time when the recipient of the allograft begins to mount a reject reaction against the allograft.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: November 5, 1996
    Assignee: Azura, Inc.
    Inventors: Randall E. Morris, Robert I. Fox, William Drell
  • Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
    Patent number: 4879213
    Abstract: A synthetic polypeptide that contains about 6 to about 40 amino acid residues that immunologically mimics the early antigen-diffuse (EA-D) protein of the Epstein-Barr virus (EBV) is disclosed, as are receptors raised to that polypeptide, methods of their use and a reagent system. A polypeptide of the present invention has an amino acid residue sequence that corresponds to the sequence of the EBV EA-D protein from about position 350 to about position 362 from the amino-terminus.
    Type: Grant
    Filed: December 5, 1986
    Date of Patent: November 7, 1989
    Assignee: Scripps Clinic and Research Foundation
    Inventors: Robert I. Fox, Richard Houghton